Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 1;32(3):183-190.
doi: 10.1097/ICU.0000000000000761.

Radiation therapy for uveal melanoma: a review of treatment methods available in 2021

Affiliations
Review

Radiation therapy for uveal melanoma: a review of treatment methods available in 2021

David A Reichstein et al. Curr Opin Ophthalmol. .

Abstract

Purpose of review: Radiation therapy has become the standard of care for the treatment of uveal melanoma. We intend to outline the current radiation therapy methods that are employed to treat uveal melanoma. We will outline their relative benefits over one another. We will also provide some background about radiation therapy in general to accustom the ophthalmologists likely reading this review.

Recent findings: Four main options exist for radiation therapy of uveal melanoma. Because the eye is a small space, and because melanomas are relatively radioresistant, oncologists treating uveal melanoma must deliver highly focused doses in high amounts to a small space. Therapies incorporating external beams include proton beam therapy and stereotactic radiosurgery. Stereotactic radiosurgery comes in two forms, gamma knife therapy and cyberknife therapy. Radiation may also be placed directly on the eye surgically via plaque brachytherapy. All methods have been used effectively to treat uveal melanoma.

Summary: Each particular radiotherapy technique employed to treat uveal melanoma has its own set of benefits and drawbacks. The ocular oncologist can choose amongst these therapies based upon his or her clinical judgment of the relative risks and benefits. Availability of the therapy and cost to the patient remain significant factors in the ocular oncologist's choice.

PubMed Disclaimer

References

    1. Jeggo P, Lavin MF. Cellular radiosensitivity: how much better do we understand it? Int J Radiat Biol 2009; 85:1061–1081.
    1. Li Y, Jia R, Ge S. Role of epigenetics in uveal melanoma. Int J Biol Sci 2017; 13:426–433.
    1. Soulieres D, Rousseau A, Tardif M, et al. The radiosensitivity of uveal melanoma cells and the cell survival curve. Graefes Arch Clin Exp Ophthalmol 1995; 233:85–89.
    1. van den Aardweg GJ, Naus NC, Verhoeven AC, et al. Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines. Invest Ophthalmol Vis Sci 2002; 43:2561–2565.
    1. Hussain RN, Coupland SE, Khzouz J, et al. Inhibition of ATM increases the radiosensitivity of uveal melanoma cells to photons and protons. Cancers 2020; 12:1388doi: 10.3390/cancers12061388. - DOI